Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Drug Discrimination in Methadone-Maintained Humans Study 3 (OMDD3)
This study has been completed.
Study NCT01068847 Information provided by University of Arkansas
First Received on February 12, 2010. Last Updated on March 6, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Drug Dependence
Additional conditions recognized in this trial
Substance-Related Disorders
More general conditions related to this trial
Mental Disorders
Interventions listed in this trial
2-4 of the drugs listed below
Additional drug interventions recognized in this trial
Cycloserine
Methadone
Naloxone
Nifedipine
Tizanidine
Verapamil
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic alpha-Agonists
Analgesics
Analgesics, Opioid
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Antibiotics, Antitubercular
Anticonvulsants
Antimetabolites
Antitubercular Agents
Antitussive Agents
Autonomic Agents
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Muscle Relaxants, Central
Narcotic Antagonists
Narcotics
Neuromuscular Agents
Neurotransmitter Agents
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Renal Agents
Reproductive Control Agents
Respiratory System Agents
Sensory System Agents
Therapeutic Uses
Tocolytic Agents
Vasodilator Agents
Sponsors listed in this trial
University of Arkansas
National Institute on Drug Abuse (NIDA)
Back to top of Main Content
